Aclaris Therapeutics, Inc. · NASDAQ:ACRS

The Vanguard Group's stake in Aclaris Therapeutics, Inc. fell to 4.60% (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 30, 2025

The Vanguard Group's stake in Aclaris Therapeutics, Inc. fell to 4.60%, 4,970,254 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).

Stake
4.60%
Shares
4,970,254
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
The Vanguard Group4.60%4,970,254

Source

View original at SEC

Related